Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • ONS-5010 CLINICAL PROGRESS
    • UNMET PATIENT NEEDS
    • REPACKAGED IV BEVACIZUMAB
    • NEW OPHTHALMIC ANTI-VEGF
    • POTENTIAL FIRST-LINE THERAPY
  • News
  • Contact

Presentations

Home / Investors / News & Events / Presentations

Presentations

Presentations

Date Title
September 2, 2022
Corporate Presentation: September 2022 1.7 MB
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2022 Outlook Therapeutics, Inc.
Privacy Policy | Disclaimer